T. Rowe Price Associates’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $40K | Sell |
|
|||||
|
2025
Q1 | $50K | Sell |
|
|||||
|
2024
Q4 | $21.8M | Sell |
|
|||||
|
2024
Q3 | $66.4M | Sell |
|
|||||
|
2024
Q2 | $28M | Buy |
|
|||||
|
2024
Q1 | $37.5M | Buy |
|
|||||
|
2023
Q4 | $27.1M | Buy |
|
|||||
|
2023
Q3 | $27.1M | Buy |
|
|||||
|
2023
Q2 | $29.8M | Buy |
|
|||||
|
2023
Q1 | $29.1M | Sell |
|
|||||
|
2022
Q4 | $37.5M | Sell |
|
|||||
|
2022
Q3 | $50.4M | Sell |
|
|||||
|
2022
Q2 | $47.3M | Buy |
|
|||||
|
2022
Q1 | $60M | Sell |
|
|||||
|
2021
Q4 | $69.5M | Buy |
|
|||||
|
2021
Q3 | $155M | Buy |
|
|||||
|
2021
Q2 | $165M | Buy |
|
|||||
|
2021
Q1 | $138M | Buy |
|
|||||
|
2020
Q4 | $117M | Buy |
|
|||||
|
2020
Q3 | $64.1M | Sell |
|
|||||
|
2020
Q2 | $66.2M | Buy |
|
|||||
|
2020
Q1 | $45.9M | Sell |
|
|||||
|
2019
Q4 | $35M | Buy |
|
|||||
|
2019
Q3 | $14.5M | Buy |
|